Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement.
about
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effectsMultiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disordersAlzheimer's disease; taking the edge off with cannabinoids?Natural Phytochemicals in the Treatment and Prevention of Dementia: An OverviewCannabinoids and Epilepsy.Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvementProlonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cellsCannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation.Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's diseaseAdelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionCritical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.Flax Fiber Hydrophobic Extract Inhibits Human Skin Cells Inflammation and Causes Remodeling of Extracellular Matrix and Wound Closure ActivationThe pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection.Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expressionCannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.The Wnt signaling pathway: aging gracefully as a protectionist?Erythropoietin: elucidating new cellular targets that broaden therapeutic strategiesProlonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction.The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.Erythropoietin and oxidative stress.Cannabinoids, endocannabinoids, and related analogs in inflammationCannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell deathCannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons.In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.Red mold fermented products and Alzheimer's disease: a review.The therapeutic potential of the endocannabinoid system for Alzheimer's disease.Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?The gastrointestinal pharmacology of cannabinoids: focus on motility.Cannabinoids: new promising agents in the treatment of neurological diseases.Cannabinoids in late-onset Alzheimer's disease.s-Methyl cysteine enhanced survival of nerve growth factor differentiated PC12 cells under hypoxic conditions.Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.
P2860
Q24606148-0EBDF883-260A-489C-905D-11B2A674B774Q24623179-374B5F37-FB37-4DAD-B50E-96EB0CAF7288Q24681412-A5C94DF3-9109-477E-B71C-3A1CA54CAA54Q26750581-75D34A11-5B0A-4645-80C0-C4D814892318Q27336451-5C76F529-D235-4174-9CD3-DB7CC180D8E2Q28394506-9D189C70-5BDB-49D9-AC4D-71CDDCF9E693Q30506148-D176EDB2-05D6-425D-A871-6AC9A460A1E6Q30670447-EE075A6C-847A-4F41-A7DF-FE7BC9081ADFQ33581824-ACFC37B0-F1B1-477A-9FA2-DBA9225C6413Q33690796-28B002F7-7286-47BF-9382-F4FB4BAD40C7Q33716712-8576A7BD-3415-4787-A3CA-830414456B1CQ34557613-F7C08388-9B04-458D-B524-6631A6B739A5Q34627188-5C0DFD9A-956C-4488-AF7B-6866FD854AB3Q34772868-00A6B4F3-4D65-49A2-8BF5-5AC847B0C336Q34898890-D614437A-F0C8-47B5-B894-2133E9647842Q35499568-8B2DDC96-E96B-41D9-9C33-9A09E570E436Q35613040-DB2BBF84-30A7-4175-804F-99A28A40720EQ35963966-293BE62C-6A85-4B25-9121-32001A02292FQ36002875-1BAFE51E-48A2-40FE-9783-361AA2EFBA74Q36155898-58BD5017-6F76-4289-ACB7-2C565F8EBD21Q36358055-5BDA5625-8A74-44AF-B0AB-2B70A22226D5Q36431803-B7928EE1-814E-4F2B-8651-EE7C86E41BD0Q36728844-F1FADB4C-2F9C-4853-A2CA-A4D7C4A889AAQ36740470-AD5D0C4C-D31F-4A90-99F1-CF37A8B8F690Q36799355-A4813008-EDA6-4808-B2C4-90CB9B3F7D75Q36836455-73B877E2-59C8-4052-AAC0-BF9C154AB20EQ36944477-CC1CF82D-9FCF-40DA-99E3-FB934CFC42ADQ37149113-C51DEECA-199E-4DB1-A0A7-1240D040AD12Q37192723-0A580F59-504D-475D-AA83-EEEC7D4F12C8Q37285921-A93E4AFC-D4B0-485E-BEF9-D46B6AA9486DQ37595135-7EBE5F4F-CDC0-48AB-97B7-CC1EC0296E87Q37622090-EE0EA485-1CA5-468F-A910-260EAD5DDDBBQ37891842-F91B8FC7-4356-489F-A21F-20F7C39B2A9EQ37997020-BBD7F0AB-C364-4F58-B2A3-6E162F8F1CA2Q38012845-AE581639-1909-4BA0-9B97-18EE3F8FDB34Q38018818-E7A6B68A-DAB2-4B4A-84CF-746503963FB6Q38269376-F3767913-6D78-4588-AA68-1F4D371B1C5FQ38383508-B2E79899-69F5-462B-B639-8E55A187CABBQ39006813-F45766B1-7093-4AC4-B322-D240A2A4373AQ39096624-21A6D5FB-887A-47F0-A67A-10FBBE7B85F1
P2860
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cannabidiol inhibits inducible ...... ase and NF-kappaB involvement.
@en
type
label
Cannabidiol inhibits inducible ...... ase and NF-kappaB involvement.
@en
prefLabel
Cannabidiol inhibits inducible ...... ase and NF-kappaB involvement.
@en
P2093
P1433
P1476
Cannabidiol inhibits inducible ...... ase and NF-kappaB involvement.
@en
P2093
Daniela De Stefano
Daniele De Filippis
Rosa Carnuccio
Teresa Iuvone
P356
10.1016/J.NEULET.2006.01.047
P407
P577
2006-02-21T00:00:00Z